FDA Approves HETLIOZ® (tasimelteon) for the Treatment of Nighttime Sleep Disturbances in Smith-Magenis Syndrome ...Middle East

WASHINGTON, Dec. 1, 2020 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved HETLIOZ® (tasimelteon) capsule and liquid formulations for the treatment of adults and children, respectively, with...

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves HETLIOZ® (tasimelteon) for the Treatment of Nighttime Sleep Disturbances in Smith-Magenis Syndrome )

Also on site :

• Nazi symbols prevalent in Ukrainian military – Le Monde
• Kremlin comments on possible US strike on Iran
• This Grammy-Winning A-Lister Just Shared His Monthly Gambling Losses on Instagram, And They're Massive